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Results. Radiation mucositis at least of
the grade 2 (patchy stage) has been
observed in all (100%) pts, usually
beginning from the 11th day (range: 6-21).
The confluent mucositis (grade 3) has
noted in 87 pts (98%) with the median
onset at 14th day (range: 6-39). Reaction
of grade 4 (confluent mucositis occupying
more than 50% of radiated mucosal area -
CME>50) has been detected. in 71 pts
(81%) with the median appearance at 21st
day (range: 9-42), remaining usually 24
days (range: 2-45) notwithstanding below
or equal 7 days in 15 pts (21%).
The incidence and duration of CME>50
has correlated significantly with the type of
fractionation - 88% of pts treated by AF
and HF developed CME>50 which took
about 28 days, compare respectively to
77% of pts and 19 days for CF. Also the
site of CME>50 origin (oral cavity+pharynx
vs. larynx+hypopharynx) was connected
significantly with its incidence and duration
- 25th vs. 20th day and 25 days vs. 19
days, respectively. The most important
factors associated directly with the time of
mucosal healing were duration of
mucositis and its supportive treatment,
maximal total score, accumulated radiation
dose (ADR), area of boost fields and total
radiation dose, but adversely - onset of
dysphagia and onset of mucosal oedema.
The overall duration of mucosal reaction
(i.e. time from the first day of irradiation up
to its complete healing) was significantly
connected directly with duration of
mucositis and its supportive treatment,
areas of radiation fields (initial, shrinking
and boost), total dose, overall radiation
treatment time (ORTT) and maximal total
score, but adversely with site of reaction
origin and with ARD. Finally, the prediction
models of severa.l mucosal reaction end-
points have been created on the base of
multiple regression function. The
increasing number of symptoms
(variables) collecting as the monitoring
progressed has improved the fit of
prediction model for crucial end-points, like
duration of mucosal healing, overall
duration of mucosal reaction, duration of
CME>50 and maximal total score.
The highest adjusted goodness-of-fit
values (adR2) for prediction models
estimated at the end of radiation treatment
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have reached at best to 0.75 (usually were
-0.5), what could meant at least 50%
variability of that reaction depends on
individual radiosensitivity of mucosal
membrane.
Conclusions. 1. High rate of mucositis
grade 4 during conventional fractionation,
reaching 75%, has been in contrast with
general opinion of its lower, 25% rate.
Methodology of this study and relatively
high proportion of patients (-20%), who
experienced such a grade within a very
short time (up to 7 days), suggests
however, that literature data could be
underestimated. 2. In spite of noted, well-
known tendency that AF has prolonged the
time of mucosal healing (on 7 days); the
overall duration of mucosal reaction has
been adversely influenced by ORTT and
ARD, what has given per saldo 1 week
shorter reaction for AF. It suggests that
radiation-free weekends during CF are not
thus important for mucosal healing like it
has believed. The overall duration of
mucosal healing in 5 fractions per week
treatment is longer than for 7 fractions per
week, provided that ARD does not exceed
12.6Gy per week and radiation fields
delivered during the weekends are
relatively small. 3. Frequent and careful
monitoring of the whole course of radiation
mucosal reaction seems to be essential for
individual prediction of its severity and
healing. This procedure claims to be
clinically useful especially for aggressive
altered fractionation or concomitant
chemo-radiotherapy, Le. for those
therapeutic methods where traditional
reporting on radiation mucosal toxicity has
been neglected.
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Introduction. Treatment modalities
based on single fraction delivery demand
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applying techniques that allow sparing
critical tissues and appropriate dose
distribution in planning target volume. The
most attractive seems to be Intensity?
Modulated Radiosurgery (IMRS). IMRT is
a treatment modality that uses varying
energy fluence across the field to assure
better conformity and steeper dose
gradients than techniques based solely on
geometric field shaping. The indications for
its use are still discussed, especially in
conjunction with stereotactic radiosurgery.
Objective. The aim of our study was to
analyze treatment plans in order to find the
most frequent situations when intensity
modulation was used and, thus, to
determine the possible indications for
IMRS.
Material and Methods. Thirty-three
treatment plans of IMRS of 220 made for
radiosurgery between October 2001 and
February 2003 were analyzed.
Results. IMRS was most commonly
used when target volume was localized in
the vicinity of organs at risk (17 cases -
51%). In 7 of these cases the need for
intensity modulation was caused both by
the necessity of sparing organs at risk and
geometric complexity of irradiated volume.
In 15 cases (45%), including the men-
tioned above, complex shape of target
volume was the reason of intensity
modulation application. In 4 cases (12%) -
multiple target volumes (2-4) - in brain
metastases and bifocal recurrence of
malignant glioma. In 3 cases (9%) - dose
escalation within the irradiated volume
(boost on gross tumor volume inside the
PTV). In two cases the use of intensity
modulation was the only way to obtain
optimal dose distribution in the target
volume of simple shape, located away of
organs at risk
Conclusions. Intensity modulation in ra-
diosurgery is a very attractive option when
there is a need for irradiation volumes
close to organs at risk. It is also useful
when "conventional" conformal techniques
cannot assure optimal dose distribution in
target volumes of complex shapes. Finally,
it is a convenient way to boost gross tumor
volume inside the PTV when prescribed
dose is delivered in single fraction.
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Purpose: To assess the influence of
total radiation dose, overall tratment time
and other clinical factors on treatment
outcome for muscle-invasive (T2,T3)
bladder cancer patients, treated with
radical radiotherapy.
Material and methods: Between 1975
and 1995, 480 consecutive patients with
T2, T3 bladder cancer were treated with
radical radiotherapy. During that period
various fractionation schedules were used:
1. conventional fractionation (once a-day,
1.8-2.5 Gy/fraction; OTT-53 days), 2.
protracted fractionation (once a-day,
pelvis- 1.6-1.7 Gy/fraction, boost- 2.0
Gy/fraction; OTT-62 days), 3. accelerated
hyperlractionated boost (pelvis- once a-
day, 2.0 Gy/fraction; boost- twice a-day,
1.3-1.4 Gy/fraction; OTT-45 days), 4.
accelerated hyperlractionation (pelvis and
boost- twice a-day, 1.2-1.5 Gy/fraction;
OTT-41 days). For the whole group of
patients mean total dose and mean overall
treatment time were: 65.5 Gy and 51 days,
respectively. Maximum-likelihood logistic
model and Cox proportional hazard model
were used to evaluate the role of total
dose, overall treatment time, T-stage,
hemoglobin level and bladder capacity
before radiotherapy. The median follow-up
was 76 months.
Results: Five-years actuarial local
control rate was 47% and overall survival
rate was 40%. Logistic model including
total dose, overall treatment time and T-
stage revealed that all those factors
significantly influenced local control
probability (p=0.021 for TO, p=0.038 for
OTT and p=0.00068 for T-stage). When
other clinical factors and tratment-related
parameters were analysed in Cox
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